. Author manuscript; available in PMC: 2013 Nov 1.

Published in final edited form as: Breast Cancer Res Treat. 2012 Oct 21;136(2):593–602. doi: 10.1007/s10549-012-2299-7

Table 3.

Interaction between TCF7L2, history of Type 2 diabetes, and breast cancer risk, The Breast Cancer Health Disparities Study

TCF7L2	Genotype	Diabetes history Cases = 399/controls = 508 OR (95 % CI)	No diabetes history Cases = 2714/controls = 3244 OR (95 % CI)	P_interaction	P_(adj)
rs3750804	CC	1.00	1.00	0.0043	0.0086
	CT	0.81 (0.61–1.08)	1.09 (0.97–1.21)
	TT	2.46 (1.28–4.73)	1.06 (0.85–1.32)
rs3814570	CC	1.00	1.00	0.0099	0.0099
rs3814570	CT/TT	0.76 (0.58–0.99)	1.13 (1.02–1.26)

OR (odds ratios) and 95 % confidence interval (CI) adjusted for age, study, BMI in referent year, and genetic admixture